Notes in Anal cancer

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	Role of chemotherapy
Published	02/18/2024	Which contouring guideline to use?
Published	02/18/2024	GI \| Anus \| 1.8.2 \| Prognosis
Published	02/18/2024	GI \| Anus \| 5.2 \| Follow up
Published	02/18/2024	GI \| Anus \| 1.1.1 \| Anatomy
Published	02/18/2024	GI \| Anus \| 1.3 \| Epidemiology
Published	02/18/2024	GI \| Anus \| 1.4 \| Risk factors
Published	02/18/2024	GI \| Anus \| 1.2 \| Pathologic classification
Published	02/18/2024	GI \| Anus \| 1.6 \| SCC \| Macroscopic and microscopic appearance
Published	02/18/2024	GI \| Anus \| 1.7.1 \| Precursor lesions
Published	02/18/2024	GI \| Anus \| 1.7.2 \| Paget disease
Published	02/18/2024	GI \| Anus \| 1.7.3 \| Neoplasia-like lesions
Published	02/18/2024	GI \| Anus \| 1.5 \| Biologic behaviour
Published	02/18/2024	GI \| Anus \| 1.8.1 \| Prognostic factors
Published	02/18/2024	GI \| Anus \| 1.9 \| Clinical features
Published	02/18/2024	GI \| Anus \| 2.1 \| Workup
Published	02/18/2024	GI \| Anus \| 2.2 \| Staging (AJCC 8th edition, 2017)
Published	02/18/2024	GI \| Anus \| 3.1 \| Management overview
Published	02/18/2024	GI \| Anus \| 3.2 \| Patient considerations
Published	02/18/2024	GI \| Anus \| 3.3 \| Treatment breaks
Published	02/18/2024	GI \| Anus \| 3.4.1 \| Surgery
Published	02/18/2024	GI \| Anus \| 3.4.2 \| Evidence for surgery vs. chemoRT
Published	02/18/2024	GI \| Anus \| 3.5.1 \| ChemoRT vs. RT alone
Published	02/18/2024	GI \| Anus \| 3.5.2 \| Chemotherapy trials
Published	02/18/2024	GI \| Anus \| 3.6.2 \| Role of brachytherapy
Published	02/18/2024	GI \| Anus \| 3.7 \| Elective inguinal LN irradiation
Published	02/18/2024	GI \| Anus \| 3.8.2 \| Salvage APR
Published	02/18/2024	GI \| Anus \| 3.8.1 \| Post-treatment biopsy
Published	02/18/2024	GI \| Anus \| 3.9 \| HIV positive patients
Published	02/18/2024	GI \| Anus \| 3.6.1 \| Role of IMRT
Published	02/18/2024	GI \| Anus \| 4.1 \| Ongoing trials - PLATO
Published	02/18/2024	GI \| Anus \| 3.6.3 \| Dose escalation
Published	02/18/2024	GI \| Anus \| 5 \| Outcomes
Published	02/18/2024	GI \| Anus \| 6 \| Metastatic disease
Published	02/18/2024	GI \| Anus \| 7 \| RT technique
Published	02/18/2024	GI \| Anus \| 8.1 \| Key trials \| ACT I (Lancet 1996; Br J Cancer 2010)
Published	02/18/2024	GI \| Anus \| 8.3 \| Key trials \| Intergroup RTOG 8704 / ECOG1289 (Flam JCO 1996)
Published	02/18/2024	GI \| Anus \| 8.2 \| Key trials \| EORTC trial (Bartelink JCO 1997)
Published	02/18/2024	GI \| Anus \| 8.4 \| Key trials \| RTOG 98-11 (Ajani JAMA 2008)
Published	02/18/2024	GI \| Anus \| 8.5 \| Key trials \| ACCORD 03 (Peiffert JCO 2012)
Published	02/18/2024	GI \| Anus \| 8.6 \| Key trials \| ACT II (James Lancet Oncol 2013)
Published	02/18/2024	GI \| Anus \| 8.8 \| Key trials \| RTOG 0529 (Kachnic IJROBP 2013)
Published	02/18/2024	GI \| Anus \| 1.1.2 \| Perianal region
Published	02/18/2024	GI \| Anus \| 8.7 \| Key trials \| Post-hoc analysis of ACT II (Glynn-Jones Lancet Oncol 2017)
Published	02/18/2024	Treatment breaks
Published	02/18/2024	GI \| Anus \| 1.2.1 \| Pathogenesis \| HPV and HIV association
Status	Last Update	Fields